The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included about 800 older men with low testosterone and symptoms associated with this ailment, including http://tinyurl.com/zwvtvex
sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent conflicting findings on testosterone treatment prompted Patel and his team to run a sizeable systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the USA suffer with low testosterone, which happens when the body fails to make enough hormones because of a difficulty with the testicles or pituitary gland. This describes loss of energy, clear aging and somebody's unexpected weight gain.
And many girls have a knee-jerk suspicion that any hormone treatment can increase
their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will probably stay the status quo for a little while, given the prohibitive cost of conducting the long term safety studies needed to win FDA acceptance that is fuller.